Related Experiment Video
Updated: Aug 10, 2025
10:28
Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs
Published on: April 14, 2015
33.3K
Harnessing the LdCsm RNA Detection Platform for Efficient microRNA Detection.
Zhenxiao Yu1, Jianan Xu1, Qunxin She1
1CRISPR and Archaea Biology Research Center, State Key Laboratory of Microbial Technology and Microbial Technology Institute, Shandong University, Qingdao 266237, China.
International Journal of Molecular Sciences
|February 11, 2023
Summary
This study introduces a novel CRISPR-based diagnostic tool using the LdCsm system for sensitive microRNA (miRNA) detection. This efficient platform shows promise for early breast cancer diagnosis and point-of-care applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Research
Background:
- MicroRNAs (miRNAs) are crucial biomarkers in cancer diagnosis and carcinogenesis.
- Current miRNA detection methods like RT-PCR are complex and time-consuming.
- CRISPR-based nucleic acid detection offers a promising alternative for efficient miRNA detection.
Purpose of the Study:
- To evaluate the LdCsm CRISPR system for direct RNA detection and quantification.
- To develop a sensitive and specific diagnostic tool for cancer-related miRNAs.
- To optimize the LdCsm platform for potential point-of-care applications.
Main Methods:
- Utilized the type III-A Csm system from Lactobacillus delbrueckii subsp. bulgaricus (LdCsm) for RNA detection.
- Employed fluorescence-quenched DNA reporters for signal generation.
- Optimized assay conditions and modified crRNA sequences for enhanced performance.
Main Results:
- Demonstrated specific detection of miR-155, a biomarker for breast cancer carcinogenesis.
- The LdCsm system exhibited robust target RNA-activated DNase activity.
- The developed detection platform showed improved sensitivity and specificity after optimization.
Conclusions:
- The LdCsm CRISPR system is a viable tool for sensitive and specific miRNA detection.
- This platform holds significant potential for developing advanced point-of-care diagnostic devices for cancer.
- Further development could lead to improved early cancer detection and prevention strategies.
